In this study, HA-PEI conjugate was designed for delivery of miR-223 duplex to macrophages due to the high capacity of PEI for encapsulation of nucleic acids and targeting ability of HA to CD44-overexpressed cancer cells and macrophages [13,23,24]. The gene discussed is CD44; the disease is cancer.